Hong Shen
沈宏
Hong Shen is a biopharma executive who, as of 2020, served as head of the Roche Shanghai Innovation Center . He appeared in that capacity at FreeS Fund's 2020 biopharma and biotech summits, where he discussed early-stage biotech entrepreneurship and partnership strategies with big pharma .
elsewhere's corpus does not otherwise cover this subject.
AI-generated — may contain errors, please verify.
Hong ShenPerson
沈宏
渲染中…
Mentioned in 3 articles
Coverage
Blue Ocean Strategy: How Early-Stage Biopharma Startups Can Break Through and Win with Big Pharma | FreeS Fund 2020 Biopharma Summit Session 3 — Registration Open
From "Me Worse" to "First in Class": How Can Biopharma Companies Compete Through Differentiation?
Beyond the "Narrow Door": A Real-World Portrait of Early-Stage Frontier Biotech Entrepreneurship in China | FreeS Fund 2020 Biotech Summit Registration Now Open
Will Today’s US Biotech Become China’s Tomorrow?
Li Feng: One Chart to Decode Biotech Innovation Opportunities | Your Complete Guide to the FreeS Fund 2020 Biomedical Summit
Three Livestreams and One Offline Symposium, Decoding the Era of Biomedical Innovation
